The expression and the tumor suppressor role of CLDN6 in colon cancer

Mol Cell Biochem. 2022 Dec;477(12):2883-2893. doi: 10.1007/s11010-022-04450-z. Epub 2022 Jun 14.

Abstract

As a member of the tight junction family, CLDN6 is a tumor suppressor in breast cancer, but its role in colon cancer is unknown. In this research, we aimed at revealing the function of CLDN6 in colon cancer. We found that colon cancer tissues lowly expressed CLDN6, and the expression of CLDN6 was negatively correlated with lymph node metastasis. Similarly, CLDN6 was lowly expressed in the colon cancer cell line SW1116, and overexpression of CLDN6 inhibited cell proliferation in vitro and in vivo. Consistently, the migration and invasion abilities of cells were significantly inhibited after CLDN6 overexpression. In addition, we demonstrated that CLDN6 may inhibit the migration and invasion abilities by activating the TYK2/STAT3 pathway. Therefore, our data indicated that CLDN6 acted as a tumor suppressor and had the potential to be regarded as a biomarker for the progression of colon cancer.

Keywords: CLDN6; Colon cancer; Invasion; Migration; Proliferation; TYK2/STAT3.

MeSH terms

  • Breast Neoplasms* / pathology
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Claudins* / genetics
  • Colonic Neoplasms* / genetics
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans

Substances

  • Claudins
  • claudin 6